OsMo
OsMo is a lysosome-targeting hNEU1 inhibitor that can be used in the study of myocardial injury[1].
Product Specifications
UNSPSC
12352005
Target
Autophagy; Reactive Oxygen Species (ROS)
Type
Reference compound
Related Pathways
Autophagy; Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB
Applications
Cancer-programmed cell death
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/osmo.html
Smiles
O=C(C1=C[C@H]([C@@H]([C@H](C1)N)NC(C)=O)OC(CC)CC)OCCN2CCOCC2
Molecular Formula
C20H35N3O5
Molecular Weight
397.51
References & Citations
[1]Zhou W, et al. A Lysosome-Targeting hNEU1 Inhibitor Treats Myocardial Infarction: A Potential Therapeutic Breakthrough. J Med Chem. 2024 Sep 26;67 (18) :16899-16911.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
More Discoveries
Explore Other Products
Browse additional items from our catalog
250494-ML650 100 µL
PRKDC (Protein Kinase, DNA-Activated, Catalytic Polypeptide, DNA-PKcs, DNAPK, DNPK1, HYRC, HYRC1, XRCC7, p350) (MaxLight 650)
Sign In for Pricing
View Details 
G2024-59 50 µg
General Transcription Factor IIA, Polypeptide 1 (GTF2A1, Transcription Factor IIA alpha/beta, TFIIA, p55) discontinued
Sign In for Pricing
View Details 
MBS9008616 Inquire
Rabbit anti-Schizosaccharomyces pombe (strain 972/24843)(Fission yeast) GHT1 Polyclonal Antibody
Sign In for Pricing
View Details